Environmental sampling of Ceratonia siliqua (carob) trees in Spain reveals the presence of the rare Cryptococcus gattii genotype AFLP7/VGIV

Revista Iberoamericana de Micologia

Volumn 32, Issue 4, 2015, Pages 269-272

  Linares, Carlos ^a   Colom, María Francisca ^a   Torreblanca, Marina ^a   Esteban, Violeta ^a   Romera, Álvaro ^a   Hagen, Ferry ^b  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Amplified fragment length polymorphism (AFLP); Antifungal susceptibility; Ceratonia siliqua; Cryptococcus gattii; Environmental sampling; Fingerprinting; Multi locus sequence typing (MLST)

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT; FUNGAL DNA;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CERATONIA SILIQUA; CRYPTOCOCCUS GATTII; ENVIRONMENTAL MONITORING; FUNGUS CULTURE; GENOTYPE; MATING TYPE; NONHUMAN; ORGANISM COLONY; SPAIN; TREE; ANTIFUNGAL RESISTANCE; CLASSIFICATION; DISEASE CARRIER; DNA FINGERPRINTING; DRUG EFFECTS; FABACEAE; FILOBASIDIELLA; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTILOCUS SEQUENCE TYPING; OLIVE TREE; PHYLOGENY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTHERN EUROPE;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; ANTIFUNGAL AGENTS; CRYPTOCOCCUS; DISEASE RESERVOIRS; DNA FINGERPRINTING; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; FABACEAE; GENOTYPE; MEDITERRANEAN REGION; MULTILOCUS SEQUENCE TYPING; OLEA; PHYLOGENY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SPAIN;

EID: 84937987371     PISSN: 11301406     EISSN: 21739188     Source Type: Journal    
DOI: 10.1016/j.riam.2014.11.002     Document Type: Article

References (25)

1. Baró T., Torres-Rodríguez J.M., De Mendoza M.H., Morera Y., Alía C. First identification of autochthonous Cryptococcus neoformans var. gattii isolated from goats with predominantly severe pulmonary disease in Spain. J Clin Microbiol 1998, 36:458-461.
2. Bovers M., Hagen F., Boekhout T. Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex. Rev Iberoam Micol 2008, 25:S4-S12.
3. Byrnes E.J., Li W., Ren P., Lewit Y., Voelz K., Fraser J.A., et al. A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients. PLoS Pathog 2011, 7:e1002205.
4. Chowdhary A., Randhawa H.S., Boekhout T., Hagen F., Klaassen C.H., Meis J.F. Temperate climate niche for Cryptococcus gattii in Northern Europe. Emerg Infect Dis 2012, 18:172-174.
5. Cogliati M., Chandrashekar N., Esposto M.C., Chandramuki A., Petrini B., Viviani M.A. Cryptococcus gattii serotype-C strains isolated in Bangalore, Karnataka, India. Mycoses 2012, 55:262-268.
6. Cogliati M., Colom M.F., Hagen F., Boekhout T. Environmental survey of Cryptococcus neoformans and C. gattii in European and Mediterranean area. Mycoses 2014, 57(Suppl. 1):29. ISHAM Working group for genotyping of C. neoformans and C. gattii.
7. Colom M.F., Hagen F., Gonzalez A., Mellado A., Morera N., Linares C., et al. Ceratonia siliqua (carob) trees as natural habitat and source of infection by Cryptococcus gattii in the Mediterranean environment. Med Mycol 2012, 50:67-73.
8. Espinel-Ingroff A., Aller A.I., Cantón E., Castañón-Olivares L.R., Chowdhary A., Córdoba S., et al. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother 2012, 56:5898-5906.
9. Espinel-Ingroff A., Chowdhary A., Cuenca-Estrella M., Fothergill A., Fuller J., Hagen F., et al. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine. Antimicrob Agents Chemother 2012, 56:3107-3113.
10. Espinel-Ingroff A., Chowdhary A., Gonzalez G.M., Guinea J., Hagen F., Meis J., et al. Isavuconazole MIC distributions and epidemiological cutoff values for the Cryptococcus neoformans-Cryptococcus gattii species complex by the CLSI broth microdilution method (M27-A3 document): a multicenter study. Antimicrob Agents Chemother 2014.
11. Hagen F., Ceresini P.C., Polacheck I., Ma H., van Nieuwerburgh F., Gabaldón T., et al. Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest. PLOS ONE 2013, 8:e71148.
12. Hagen F., Colom M.F., Swinne D., Tintelnot K., Iatta R., Montagna M.T., et al. Autochthonous and dormant Cryptococcus gattii infections in Europe. Emerg Infect Dis 2012, 18:1618-1624.
13. Hagen F., Illnait-Zaragozi M.T., Bartlett K.H., Swinne D., Geertsen E., Klaassen C.H., et al. In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrob Agents Chemother 2010, 54:5139-5145.
14. Hagen F., Khayhan K., Theelen B., Kolecka A., Polacheck I., Sionov E., et al. Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex. Fungal Genet Biol 2015, 10.1016/j.fgb.2015.02.009.
15. Kidd S.E., Chow Y., Mak S., Bach P.J., Chen H., Hingston A.O., et al. Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States. Appl Environ Microbiol 2007, 73:1433-1443.
16. Litvintseva A.P., Thakur R., Reller L.B., Mitchell T.G. Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa. J Infect Dis 2005, 192:888-892.
17. Loperena-Alvarez Y., Ren P., Li X., Schoonmaker-Bopp D.J., Ruiz A., Chaturvedi V., et al. Genotypic characterization of environmental isolates of Cryptococcus gattii from Puerto Rico. Mycopathologia 2012, 170:279-285.
18. Meyer W., Aanensen D.M., Boekhout T., Cogliati M., Diaz M.R., Esposto M.C., et al. Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol 2009, 47:561-570.
19. Meyer W., Castañeda A., Jackson S., Huynh M., Castañeda E. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 2003, 9:189-195. IberoAmerican Cryptococcal Study Group.
20. Morera N., Hagen F., Juan-Sallés C., Artigas C., Patricio R., Serra J.I., et al. Ferrets as sentinels of the presence of pathogenic Cryptococcus species in the Mediterranean environment. Mycopathologia 2014, 178:145-151.
21. Morera N., Juan-Sallés C., Torres J.M., Andreu M., Sánchez M., Zamora M.Á., et al. Cryptococcus gattii infection in a Spanish pet ferret (Mustela putorius furo) and asymptomatic carriage in ferrets and humans from its environment. Med Mycol 2011, 49:779-784.
22. Ngamskulrungroj P., Gilgado F., Faganello J., Litvintseva A.P., Leal A.L., Tsui K.M., et al. Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties. PLoS ONE 2009, 4:e5862.
23. Park B.J., Wannemuehler K.A., Marston B.J., Govender N., Pappas P.G., Chiller T.M. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23:525-530.
24. Springer D.J., Chaturvedi V. Projecting global occurrence of Cryptococcus gattii. Emerg Infect Dis 2010, 16:14-20.
25. Velagapudi R., Hsueh Y.P., Geunes-Boyer S., Wright J.R., Heitman J. Spores as infectious propagules of Cryptococcus neoformans. Infect Immun 2009, 77:4345-4355.